Collagène marin de Bretagne peau sublimée anti-âge
Food supplement declared in France, declaration No 2023-7-328
Collagène marin de Bretagne peau sublimée anti-âge, from Pharm nature micronutrition, is a food supplement declared in France. Status: withdrawal from the market announced for 1 February 2027. Main ingredients: Malpighia glabra 90 mg per day, Copper, Selenium, Vitamin A, Ubiquinone. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- Pharm nature micronutrition
- Status
- Withdrawal from the market announced for 1 February 2027
- Form
- Powder
- Daily dose
- 1 dose de 12 g
- Directions for use
- A diluer dans 200 ml d'eau froide ou tiède, le matin de préférence
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women
- Objectives stated by the manufacturer (these are not authorised claims)
- Skin
- Flavourings
- Orange
Declaration 197487, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Malpighia glabra L. | Fruit (pulpe) | Poudre (de plantes séchées ou broyées) | 90 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Ubiquinone | not declared |
| Collagène marin | not declared |
| Hyaluronate de sodium | not declared |
| Lutéine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| cupric gluconate | Copper | 5,000 µg | 2,000 µg |
| sodium selenite | Selenium | 255 µg | 50 µg |
| retinyl acetate | Vitamin A | 3,000 µg d'équivalent rétinol | 800 µg |
Additives
E330, E504, E331, E960, E955
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Regulatory points
- Information
Withdrawal from the market announced for 1 February 2027, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Ubiquinone
Read the warning, when it applies and the studies cited
Coenzyme Q10 (UBIQUINONE-10)
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).
Sources cited by Health Canada (2)
- Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
- Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial
Applies to products providing more than 100 mg of Coenzyme Q10 per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).
Sources cited by Health Canada (3)
- Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
- Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
- Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report
Condition of application: Migraine prophylaxis/prevention.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- COLLAGÈNE MARIN DE BRETAGNE PEAU SUBLIMÉE ANTI-ÂGE Nature Attitude, declared in 2019, withdrawn from the market : different composition: 3 ingredient(s) added, 1 missing
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Collagène marin de Bretagne peau sublimée anti-âge: composition and regulation”, https://compoatlas.com/en/supplements/products/197487-collagene-marin-de-bretagne-peau-sublimee-anti-age, updated 15 November 2026.